Background Osteoarthritis (OA) is the most common form of arthritis. Published guidelines
and expert opinion are divided over the relative role of acetaminophen (also called …

… Towheed has received speaking fees from and/or serves on the advisory board for Amgen,
Novartis, Bristol-Myers Squibb, Hoffman-La Roche, and Schering (less than $10,000 each). …

Background Osteoarthritis (OA) is a common form of arthritis and is often associated with
significant disability and impaired quality of life. This is an update of a Cochrane review first …

Background: The Medical Outcomes Study 36-item Short Form (SF-36) is a widely used
measure of health-related quality of life. Normative data are the key to determining whether a …

Background and Objectives A better understanding of the pathogenesis of chronic postsurgical
pain is needed in order to develop effective prevention and treatment interventions. The …

Background Rheumatoid arthritis (RA) is a systemic auto‐immune disorder, involving persistent
joint inflammation. NSAIDs are used to control the symptoms of RA, but are associated …

… Towheed TE. The impact of musculoskeletal disorders in Canada. Ann Roy Coll Physicians
… Towheed TE. Systematic review of therapies for osteoarthritis of the hand. Osteoarthritis …

We systematically reviewed randomized controlled trials (RCTs) of pharmacological therapy
in knee osteoarthritis (OA), published between 1966 and August 1994. RCTs were …

… Towheed has received financial support from Abbvie and Bristol-Meyers-Squibb and
research funding from the Canadian Institutes of Health Research. DD -Shore. and S. …

OBJECTIVE We aimed to explore whether frailty was associated with fracture risk and whether
frailty could modify the propensity of type 2 diabetes toward increased risk of fractures. …